A carregar...
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy
The risk of infection in patients receiving immune checkpoint inhibitor (ICI) therapy is not well understood. Immune‐related adverse events requiring immunosuppressive therapy may impact infection risk. ICIs may induce an exaggerated immune response to latent infection. We assessed the incidence and...
Na minha lista:
| Publicado no: | Cancer Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724496/ https://ncbi.nlm.nih.gov/pubmed/33159505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3532 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|